Helminth Coinfection Alters Monocyte Activation, Polarization, and Function in Latent


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 16 09 2019
accepted: 19 12 2019
pubmed: 19 1 2020
medline: 9 9 2020
entrez: 19 1 2020
Statut: ppublish

Résumé

Helminth infections are known to influence T and B cell responses in latent tuberculosis infection (LTBI). Whether helminth infections also modulate monocyte responses in helminth-LTBI coinfection has not been fully explored. To this end, we examined the activation, polarization, and function of human monocytes isolated from individuals with LTBI with (

Identifiants

pubmed: 31953351
pii: jimmunol.1901127
doi: 10.4049/jimmunol.1901127
pmc: PMC7033029
mid: NIHMS1547396
doi:

Substances chimiques

Antigens, CD 0
Cytokines 0

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1274-1286

Subventions

Organisme : Intramural NIH HHS
ID : Z99 AI999999
Pays : United States

Informations de copyright

Copyright © 2020 by The American Association of Immunologists, Inc.

Références

Annu Rev Immunol. 2013;31:475-527
pubmed: 23516984
Nat Rev Immunol. 2003 Sep;3(9):733-44
pubmed: 12949497
J Investig Med. 1996 Aug;44(6):312-23
pubmed: 8795295
J Infect Dis. 2016 Aug 1;214(3):479-88
pubmed: 27389351
Immunol Rev. 2008 Dec;226:191-204
pubmed: 19161425
Int J Tuberc Lung Dis. 2003 Nov;7(11):1083-91
pubmed: 14598969
PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2640
pubmed: 24427320
J Infect Dis. 2006 Jan 15;193(2):196-204
pubmed: 16362883
Trop Med Int Health. 2006 Apr;11(4):551-8
pubmed: 16553939
PLoS Negl Trop Dis. 2015 Feb 10;9(2):e0003491
pubmed: 25668740
Eur J Immunol. 2006 Mar;36(3):631-47
pubmed: 16479545
Front Immunol. 2018 Jul 30;9:1726
pubmed: 30105020
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Mucosal Immunol. 2011 May;4(3):246-51
pubmed: 21412228
PLoS Negl Trop Dis. 2009 Jul 28;3(7):e489
pubmed: 19636364
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087937
J Exp Med. 2011 Aug 29;208(9):1863-74
pubmed: 21825018
Clin Exp Immunol. 2007 Jan;147(1):45-52
pubmed: 17177962
J Infect Dis. 2009 Jun 15;199(12):1827-37
pubmed: 19456233
PLoS Pathog. 2018 Oct 26;14(10):e1007154
pubmed: 30365557
J Clin Invest. 2015 Dec;125(12):4699-713
pubmed: 26571397
Annu Rev Immunol. 2008;26:421-52
pubmed: 18303997
Cell Immunol. 2013 Sep-Oct;285(1-2):69-75
pubmed: 24099792
J Immunol. 2003 Dec 15;171(12):6723-32
pubmed: 14662876
Annu Rev Immunol. 2004;22:157-80
pubmed: 15032577
Immunol Rev. 2015 Mar;264(1):264-75
pubmed: 25703565
J Immunol. 2009 Mar 15;182(6):3793-800
pubmed: 19265158
Infect Immun. 2015 Nov 23;84(2):425-31
pubmed: 26597982
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Cell Host Microbe. 2014 Jun 11;15(6):741-52
pubmed: 24922576
Annu Rev Immunol. 2005;23:515-48
pubmed: 15771580
Microbiol Spectr. 2017 Jan;5(1):
pubmed: 28155806
Elife. 2013 Nov 12;2:e01086
pubmed: 24220507
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):679-91
pubmed: 9517576
Front Immunol. 2017 Dec 22;8:1864
pubmed: 29312343
Trends Immunol. 2016 Sep;37(9):597-607
pubmed: 27501916
J Immunol. 2015 Sep 1;195(5):2241-50
pubmed: 26202988
PLoS Negl Trop Dis. 2019 Mar 21;13(3):e0007265
pubmed: 30897083
Immunol Rev. 2014 Nov;262(1):179-92
pubmed: 25319335
Nat Rev Immunol. 2012 Jul 13;12(8):581-91
pubmed: 22790178
PLoS Negl Trop Dis. 2017 Feb 13;11(2):e0005390
pubmed: 28192437
Curr Top Microbiol Immunol. 1996;215:71-96
pubmed: 8791710
PLoS One. 2019 Oct 15;14(10):e0223722
pubmed: 31613921
Semin Immunol. 2014 Dec;26(6):471-85
pubmed: 25453226
Nat Rev Immunol. 2011 Jun;11(6):375-88
pubmed: 21610741
Adv Exp Med Biol. 2013;785:49-56
pubmed: 23456837
Crit Rev Immunol. 2017;37(2-6):463-481
pubmed: 29773030
Infect Immun. 1994 Jun;62(6):2515-20
pubmed: 7910594
PLoS One. 2017 Jun 28;12(6):e0179701
pubmed: 28658262

Auteurs

Anuradha Rajamanickam (A)

National Institutes of Health-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai 600031, India.

Saravanan Munisankar (S)

National Institutes of Health-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai 600031, India.

Chandrakumar Dolla (C)

National Institute for Research in Tuberculosis, Chennai 600031, India; and.

Pradeep A Menon (PA)

National Institute for Research in Tuberculosis, Chennai 600031, India; and.

Thomas B Nutman (TB)

Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Subash Babu (S)

National Institutes of Health-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai 600031, India; sbabu@mail.nih.gov.
Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH